Skip to main content
. 2020 May 6;12(5):1174. doi: 10.3390/cancers12051174

Figure 2.

Figure 2

Kaplan–Meier curves for overall survival according to the leukemic stem frequency in patients treated by hypomethylating agents (CD34+CD38CD123+ % ≤8%: solid line; >8%: dashed line).